- Home
- SONN vs EVAX Comparison
SONN vs EVAX Comparison
Compare SONN & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- EVAX
- Stock Information
- Founded
- SONN N/A
- EVAX 2008
- Country
- SONN United States
- EVAX Denmark
- Employees
- SONN N/A
- EVAX N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SONN Health Care
- EVAX Health Care
- Exchange
- SONN Nasdaq
- EVAX Nasdaq
- Market Cap
- SONN 21.4M
- EVAX 17.8M
- IPO Year
- SONN N/A
- EVAX 2021
- Fundamental
- Price
- SONN $4.46
- EVAX $6.99
- Analyst Decision
- SONN Strong Buy
- EVAX Strong Buy
- Analyst Count
- SONN 1
- EVAX 2
- Target Price
- SONN $20.00
- EVAX $11.00
- AVG Volume (30 Days)
- SONN 1.1M
- EVAX 4.5M
- Earning Date
- SONN 08-13-2025
- EVAX 10-30-2025
- Dividend Yield
- SONN N/A
- EVAX N/A
- EPS Growth
- SONN N/A
- EVAX N/A
- EPS
- SONN N/A
- EVAX N/A
- Revenue
- SONN $1,000,000.00
- EVAX $3,176,000.00
- Revenue This Year
- SONN $5,376.22
- EVAX N/A
- Revenue Next Year
- SONN N/A
- EVAX $425.50
- P/E Ratio
- SONN N/A
- EVAX N/A
- Revenue Growth
- SONN 1689.52
- EVAX 1042.45
- 52 Week Low
- SONN $1.08
- EVAX $1.20
- 52 Week High
- SONN $19.30
- EVAX $15.50
- Technical
- Relative Strength Index (RSI)
- SONN 44.44
- EVAX 70.17
- Support Level
- SONN $4.25
- EVAX $5.81
- Resistance Level
- SONN $6.15
- EVAX $7.34
- Average True Range (ATR)
- SONN 0.64
- EVAX 0.84
- MACD
- SONN -0.21
- EVAX 0.19
- Stochastic Oscillator
- SONN 9.90
- EVAX 89.00
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.